<DOC>
	<DOC>NCT00893386</DOC>
	<brief_summary>The purpose of this study is to characterize the removability of the Attain StarFix速 Model 4195 Left Ventricular (LV) Lead (StarFix速). The goal of the trial is to evaluate the lead removal success in patients that are indicated for left ventricular lead removal. This study is required by the Food and Drug Administration (FDA) as a condition of approval for the Attain StarFix速 Model 4195 LV Lead.</brief_summary>
	<brief_title>Attain StarFix速 4195 Lead Extraction Study</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Subjects with a Class I/II indication and/or physician discretion for left ventricular lead removal Medtronic Model 4195 LV lead implanted for at least 181 days at time of extraction, or other Medtronic LV Lead (nonModel 4195) implanted for at least 181 days at time of extraction, or Medtronic Model 4195 LV lead implanted for 90180 days Intention to remove the LV lead prior to the extraction procedure Subject is 18 years of age or older Subject (or subject's legally authorized representative) has signed and dated the Patient Consent Form and is willing and able to comply with the protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Extraction</keyword>
	<keyword>Removal</keyword>
	<keyword>Lead</keyword>
	<keyword>Heart Failure</keyword>
</DOC>